Roger Dmochowski, MD
Dr. Roger R. Dmochowski is Professor at the Department of Urology at Vanderbilt University in Nashville, Tennessee. He is also Clinical Assistant Professor in Surgery at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. Dr. Dmochowski has published more than 85 articles and book chapters, 200 abstracts, and has given over 100 presentations at various national and international meetings. He has been featured in videotapes and CD-ROMS on managing urinary incontinence. Dr. Dmochowski is on the editorial board for the World Journal of Urology, Neurourology and Urodynamics, International Journal of Urogynecology, and the AUA Office of Education CD-ROM Series. He is a reviewer for the Journal of Urology, and Urology. He is a Fellow of the American College of Surgeons and a member of the American Urological Association and International Continence Society. Dr. Dmochowski has been granted the Zimskind Award from the Urodynamics Society for his accomplishment in clinical treatment for incontinence. His current research interests are outcomes of incontinence therapies with a particular emphasis on quality of life issues. He also is active in bio materials evaluation.
Hann-Chorng Kuo, MD
Dr. Kuo is the Chairman and Professor of Urology in the Department of Urology, School of Medicine of Tzu Chi University in Hualien, Taiwan. Dr. Kuo is the President of Taiwanese Continence Society. He graduated from National Taiwan University, and received resident training in National Taiwan University Hospital. Dr. Kuo has published extensively on his clinical trials involving intravesical heparin and resin iferatoxin for IC and OAB. He has also been involved in many global clinical trials of OAB and has 20 grants from the National Science Council and Department of Health in Taiwan. Dr. Kuo is a world leader in the application of botulinum toxin to the treatment of IC, OAB and enlarged prostate. He has published more than 100 peer reviewed papers and written more than 10 books. Dr. Kuo is the Editor-in-Chief of Tzu Chi Medical Journal and Incontinence & Pelvic Floor Dysfunction, an official journal of the Taiwanese Continence Society and Taiwan Urogynecological Association. He is a reviewer of the Journal of Urology, Urology, European Urology and Neurourology & Urodynamics.
Tomohiro Ueda, MD, PhD
Dr. Ueda is the Chief Urologist at the Department of Urology in Kyoto City Hospital, and Clinical Professor, Kyoto University Hospital, Kyoto, Japan. Dr. Ueda did his residency in Urology at Kyoto University, Kyoto, Japan where he also received his PhD. He has extensive clinical experience in urinary incontinence and IC. Since 1997, Dr. Ueda has been studying pathophysiological IC condition using a novel oral agents including IPD-1151T (Suplatast tosilate) in global clinical trials. Dr. Ueda has also coordinated the clinical IC projects performed in Japan. Dr. Ueda has served as the President in the first meeting of International Consultation on Interstitial Cystitis, Japan (ICICJ) in 2003 with 27 representatives from all five continents and over 14 countries, and has provided the first step for establishing the internationally approved diagnostic criteria of IC. Dr. Ueda has also contributed to organizing the first IC patient group, Tomo-no-ki, in Japan and founded NPO: Comfortable Urology Network (CUN) in 2005. Dr. Ueda has organized the 2nd ICICJ in Kyoto in March 2007 and remains involved in world research groups such as International Consultation on Incontinence, NIH symposiums and AUA/SUFU.
Naoki Yoshimura, MD, PhD
Naoki Yoshimura, MD, PhD is Professor of Urology and Pharmacology & Cell Biology, and Director of Neuro-urological Research at the University of Pittsburgh School of Medicine. He received his medical and doctoral degrees from Kyoto University, Japan and completed a residency in urological surgery in Kyoto. He also completed a post-doctoral fellowship in the Department of Pharmacology at the University of Pittsburgh. Dr. Yoshimura's clinical and basic research interests focus on neural pathways that control the lower urinary tract, and on lower urinary tract dysfunction caused by various pathological conditions such as spinal cord injury, interstitial cystitis, diabetes mellitus, and Parkinson's disease.
Leaf Huang, PhD
Leaf Huang received his Ph.D. in biophysics at Michigan State University. He was previously at the University of Tennessee, Knoxville (1976–1991) and at the University of Pittsburgh (1991–2005) as a faculty member. In July 2005, he was appointed as a Fred Eshelman Distinguished Professor at UNC Eshelman School of Pharmacy and chair the Division of Molecular Pharmaceutics, a position he held until 2012. Huang has published over 320 peer-reviewed articles, over 120 invited reviews/book chapters, and has co-edited two books. The Laboratory of Drug Targeting has been working on liposomes and immunoliposomes for drug delivery. Current activities are focused in the development of nonviral vectors for gene (including siRNA) therapy, and receptor mediated drug and vaccine targeting using self-assembled nanoparticles. The technologies are tested for therapy of cancer and liver diseases in animal models.
William C. de Groat, PhD
Dr. de Groat is interested in the autonomic nervous system and the neural regulation of pelvic visceral functions. Current studies focus on the reflex control of the urogenital tract and the mechanisms underlying transmission at central and peripheral autonomic synapses. These experiments are designed to examine (1) the neurotransmitters in the reflex pathways, (2) neuroplasticity during postnatal development or following neural injury, (3) the neural pathways responsible for the detection of visceral pain, and (4) the actions of drugs used to treat urogenital dysfunction. Experiments are conducted on a variety of preparations ranging from intact animals to isolated tissues, like spinal cord slices and dissociated neurons.